Print Page | Sign In | Join
Business Wire Life Sciences News (US)
Share |

Omnicell Enters Partnership with Atrium Health to Provide Technology and Intelligence to Help Improve Medication ManagementOpen in a New Window

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Enters Partnership with Atrium Health to Provide Technology and Intelligence to Help Improve Medication Management

 

Vizient Announces Product Categories for Quarter 3 National Group Buys ProgramOpen in a New Window

IRVING, Texas--(BUSINESS WIRE)--Vizient announces the product categories and supplier savings opportunities available as part of its Quarter 3 National Group Buys Program.

 

Dr. Reddy’s announces the launch of over-the-counter, store-brand equivalent of Allegra-D® 12 HR Allergy and Congestion Extended-Release Tablets (fexofenadine HCl 60 mg and pseudoephedrine HCl 120 mg) in the U.S. MarketOpen in a New Window

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg Extended-Release Tablets, USP, an over-the-counter (OTC) store-brand equivalent of Allegra-D® 12 HR Allergy and Congestion Extended-Release Tablets, in the United States market, as approved by the U.S. Food and Drug Administra

 

Sensient Technologies Corporation Elects Carol Jackson to its Board of DirectorsOpen in a New Window

MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies today announced the election of Carol Jackson to its Board of Directors, effective December 1, 2019. Ms. Jackson is Chairman, President, and Chief Executive Officer of Harbison Walker International, the largest supplier of ceramic refractories in the U.S. with operations in the U.S., Mexico, Europe, and Southeast Asia and commercial interests globally. The 150-year-old company is private and generates revenues of between $500 million to $1 billi

 

Flex Pharma Announces Rights DividendOpen in a New Window

BOSTON--(BUSINESS WIRE)--Flex Pharma, Inc. (Nasdaq: FLKS) announced that its Board of Directors today declared a special dividend on the Company’s common stock of one right per share of outstanding common stock. The rights will be paid on July 19, 2019 to shareholders of record as of close of business on July 18, 2019. Flex Pharma has not listed, and does not intend to list, the rights for trading on any exchange. The terms of the rights are described in Flex Pharma’s definitive proxy statement

 

ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2019 Operating ResultsOpen in a New Window

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2019 Operating Results

 

Ironwood Pharmaceuticals to Host Second Quarter 2019 Investor Update CallOpen in a New Window

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its second quarter 2019 investor update conference call and webcast at 4:30 p.m. Eastern Time on Tuesday, July 30, 2019. Individuals interested in participating in the call should dial (866) 393-4306 (U.S. and Canada) or (734) 385-2616 (international) using conference ID number 1896718. To access the webcast, please visit the Investors section of Ironwood’s website at www.ironwoodpharma

 

Henry Schein, Inc. Awards Fourth Annual Henry Schein Cares Medals in the Medical Category; Names LifeNet International ‘Best in Class’Open in a New Window

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Inc. Awards Fourth Annual Henry Schein Cares Medals In The Medical Category; Names LifeNet International 'Best In Class'

 

Manhattan Scientifics Announces Breakthrough Device for Detection of CancerOpen in a New Window

NEW YORK--(BUSINESS WIRE)--Manhattan Scientifics Inc.’s (OTC: QB MHTX) former wholly-owned subsidiary that was initially funded by MHTX, Imagion Biosystems Ltd (ASX:IBX) over a nine-year period has received confirmation from the Food and Drug Administration (FDA) that the MagSense System and Test for staging HER2 breast cancer has qualified for and been granted designation as a breakthrough device. The cancer diagnostic technology further develops the early work of physicist Edward R. Flynn, Ph

 

LC GC® Presents Webcast on Automated Volatiles AnalysisOpen in a New Window

CRANBURY, N.J.--(BUSINESS WIRE)--<a href="https://twitter.com/hashtag/Chromatography?src=hash" target="_blank">#Chromatography</a>--LC GC® Presents Webcast on Automated Volatiles Analysis

 

PER® Global Presents the 4th Annual European Congress on Immunotherapies in Cancer™ in BarcelonaOpen in a New Window

CRANBURY, N.J.--(BUSINESS WIRE)--PER® Global Presents the 4th Annual European Congress on Immunotherapies in Cancer™ in Barcelona

 

Sam’s Club® Is Partnering with Lucid Hearing® and Liberty Hearing Aids® to Provide the Latest Hearing Technology with Prices that Undercut National CompetitorsOpen in a New Window

FORT WORTH, Texas--(BUSINESS WIRE)--<a href="https://twitter.com/hashtag/LucidHearing?src=hash" target="_blank">#LucidHearing</a>--Lucid Hearing has partnered with Sam's Club to introduce the latest hearing technology coupled with pricing that undercuts the competition.

 

The American Journal of Managed Care® Adds Innovation and Value Initiative to Its Strategic Alliance Partnership ProgramOpen in a New Window

CRANBURY, N.J.--(BUSINESS WIRE)--The American Journal of Managed Care® Adds Innovation and Value Initiative to Its Strategic Alliance Partnership Program

 

Peak Health Announces the Release of “Diabet” - a 100% Natural, Plant-Based Supplement That Shows Breakthrough Potential for Supporting Healthy Blood Sugar LevelsOpen in a New Window

LOS GATOS, Calif.--(BUSINESS WIRE)--<a href="https://twitter.com/hashtag/EndoPhytoSystem?src=hash" target="_blank">#EndoPhytoSystem</a>--Peak Health announces the release of “Diabet” - a 100% natural, plant-based supplement that shows breakthrough potential for supporting healthy blood

 

Battelle Organized Workshop Advances International Environmental Research Collaboration, Big Data Interoperability, Terrestrial Carbon ResearchOpen in a New Window

BOULDER, Colo.--(BUSINESS WIRE)--Battelle representatives are participating this week in the TERENO NEON Carbon Workshop 2019 in Düren, Germany, emphasizing the organization’s commitment to environmental research infrastructure (RI), data sharing and interoperability, worldwide research collaboration and building the next generation of researchers. The workshop focuses on using big data from the TERrestrial Environmental Observatories (TERENO), Integrated Carbon Observation System (ICOS) and th

 

Transgene Receives MHRA Approval for a Clinical Trial of TG6002, a Next-generation Oncolytic Virus, Administered by Intrahepatic Artery Infusion in Patients with Colorectal Cancer with Liver MetastasesOpen in a New Window

STRASBOURG, France--(BUSINESS WIRE)--<a href="https://twitter.com/search?q=%24TNG&src=ctag" target="_blank">$TNG</a> <a href="https://twitter.com/hashtag/OncolyticVirus?src=hash" target="_blank">#OncolyticVirus</a>--Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of solid tumors, today announces it has received the approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to proceed with a Phase 1/2a clinical trial of TG6002 administered by intrahepatic artery (IHA) infusion in colorectal cancer patients with unresectable liver metastases (CRLM). TG6002 is a next-gene

 

Study Shows Spatial Biology Is Essential for Predicting Response to Immuno-Oncology TreatmentOpen in a New Window

MENLO PARK, Calif.--(BUSINESS WIRE)--Study published in JAMA Oncology shows spatial biology is essential for predicting response to immuno-oncology treatment

 

Special Aerospace Services Unveils Restored Apollo Test Capsule in ColoradoOpen in a New Window

ARVADA, Colo.--(BUSINESS WIRE)--<a href="https://twitter.com/hashtag/aerospace?src=hash" target="_blank">#aerospace</a>--Special Aerospace Services celebrates Apollo space program with unveiling of Apollo 16 test capsule in Arvada, Colorado.

 

UnitedCoatings Group Announces Acquisition of CoorsTek MedicalOpen in a New Window

RUBBIANO, Italy--(BUSINESS WIRE)--UnitedCoatings Group, together with its medical division (Eurocoating SpA, Surface Dynamics, NanoSurfaces Industries, Anteco and Eurocoating Medical Technology Wuxi), a leading global supplier of integrated contract manufacturing solutions to medical device OEMs, announced today that, after its acquisition of NanoSurfaces from CoorsTek Medical in 2018, it has acquired 100% of CoorsTek Medical LLC from CoorsTek LLC. Based in Fort Worth, TX, CoorsTek Medical has

 

CTD Holdings Scientific Advisory Board Endorses Alzheimer’s Disease as Next Indication for Company’s Trappsol® Cyclo™ Drug Development ProgramOpen in a New Window

ALACHUA, Fla.--(BUSINESS WIRE)--CTD Holdings, Inc. (OTCQB: CTDH), a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, today announced that the Company’s Scientific Advisory Board endorsed Alzheimer’s Disease as the company’s next drug development indication. The Scientific Advisory Board met via videoconference on July 17, 2019. The endorsement was made based on the company’s data from an ongoing expanded access

 

TransPerfect Medical Device Solutions Offers First AI-Powered Solution for MDR and IVDR Content ComplianceOpen in a New Window

NEW YORK--(BUSINESS WIRE)--TransPerfect Medical Device Solutions (MDS), the world’s largest provider of language services and process automation technology to the device industry, today announced the division’s certification to ISO 18587 for the application of artificial intelligence (AI) in medical device translation. TransPerfect’s AI solutions are specifically designed to support the requirements of MDR and IVDR with special emphasis on labeling and post-market surveillance. AI-Enabled Servi

 

New Research Demonstrates Advantages of ExactechGPS® for Knee and Shoulder Joint ReplacementOpen in a New Window

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of bone and joint restoration products and biologic solutions for extremities, hip and knee, announced today that new research demonstrates improved surgical experience and advantages of ExactechGPS®, a computer-assisted technology that provides knee and shoulder surgeons real-time intraoperative feedback in the sterile field. Eight of these new studies were recently featured at the 19th Annual Meeting of the International S

 

Philips Future Health Index 2019 Finds US Among Leaders In EMR Use and AI Spend, but Overall Digital Health Technology Adoption MixedOpen in a New Window

ANDOVER, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its U.S. Future Health Index (FHI) 2019 report, showing that while American healthcare professionals are among the leaders in leveraging digital health records1 (DHRs), the United States falls behind the 15-country average for most other digital technologies examined. Digital health technologies have the potential to reduce healthcare professional workload, curb healthcar

 

Bone Cement Market in US 2019-2023 | 6% CAGR Projection Over the Next Five Years | TechnavioOpen in a New Window

LONDON--(BUSINESS WIRE)--<a href="https://twitter.com/hashtag/HealthcareEquipment?src=hash" target="_blank">#HealthcareEquipment</a>--The bone cement market in the US is expected to post a CAGR of more than 6% during the period 2019-2023, according to Technavio.

 

ITWP, Parent Company of Toluna, Harris Interactive Europe, and KuRunData, Announces New and Expanded Executive TeamOpen in a New Window

WILTON, Conn.--(BUSINESS WIRE)--ITWP, parent company of Toluna, Harris Interactive Europe and KuRunData, today announced the addition of Michele Morelli as Senior Vice President of Global Marketing Strategy, along with the promotions of Tsahi Ben-Yosef to Senior Vice President of Product Innovation and Mathilde Lelievre to Executive Vice President of Global Operations. This new, expanded senior team provides extensive expertise on coupling strategy, supply and product to support the continued g

 

Horizon Therapeutics plc Announces U.S. FDA Acceptance of its New Drug Application to Make PROCYSBI® (Cysteamine Bitartrate) Available as Oral Granules in PacketsOpen in a New Window

DUBLIN--(BUSINESS WIRE)--Horizon announced that the U.S. FDA has accepted its New Drug Application for PROCYSBI® Delayed-Release Oral Granules in Packets.

 

OncoCell MDx Appoints Renowned Urologic Pathologist as Chief Medical OfficerOpen in a New Window

ROYAL OAK, Mich.--(BUSINESS WIRE)--<a href="https://twitter.com/hashtag/ExecutivesAndManagement?src=hash" target="_blank">#ExecutivesAndManagement</a>--OncoCell MDx an immunogenomics platform company developing noninvasive molecular diagnostic assays, appoints Kirk Wojno M.D., as Chief Medical Officer

 

Pear Therapeutics Announces FDA Submission for Somryst™, a Prescription Digital Therapeutic for the Treatment of Adults with Chronic Insomnia and DepressionOpen in a New Window

BOSTON--(BUSINESS WIRE)--Pear Therapeutics today announced the filing of a submission to the U.S. Food and Drug Administration (FDA) seeking marketing authorization for Somryst™, a prescription digital therapeutic (PDT) intended for use in the treatment of adults with chronic insomnia and depression. Depression is the most common co-occurring disorder with insomnia.1 Somryst is intended to provide tailored neurobehavioral interventions, specifically Cognitive Behavioral Therapy for insomnia (CB

 

Elanco Finalizes Acquisition of Aratana TherapeuticsOpen in a New Window

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN), today finalized the acquisition of Aratana Therapeutics (NASDAQ: PETX), a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, and developer of the first-of-its-kind canine NSAID for osteoarthritis, Galliprant®. This transaction allows Elanco to capture the full value of growing product Galliprant®, in which Elanco has had the exclusive rights to develop, m

 

Gilead to Present New Data on HIV Prevention, Treatment and Cure Research at IAS 2019Open in a New Window

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) today announced that new data from the company’s HIV research and development programs will be presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) being held in Mexico City from July 21-24. Fifteen abstracts, along with community-focused symposia and workshops, reflect Gilead’s ongoing commitment to scientific innovation, a key pillar to addressing unmet and evolving medical needs in HIV

 

Merry X-Ray Corporation Announces Strategic Shift to a Customer-Centric Focus As MXR The Imaging Solution CompanyOpen in a New Window

SAN DIEGO--(BUSINESS WIRE)--MXR The Imaging Solution Company has developed offerings into MRI, CT, and ultrasound imaging equipment and services.

 

About BioFlorida

BioFlorida represents 6,200 establishments and research organizations in the biopharmaceuticals, medical technology, healthIT and bioagriculture sectors that collectively employ 87,000 Floridians.

 

Members of the BioFlorida network include emerging and established life science companies, universities, research institutions, hospitals, medical centers, incubators, economic development agencies, investors and service providers.

 

NEW regional sponsorship opportunities available.

Connect